Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG
Arianne M. Brandsma, Sina Bondza, Mitchell Evers, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 115

Showing 26-50 of 115 citing articles:

A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases
Fabian Bohländer
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions
Lara Gibellini, Rebecca Borella, Elena Santacroce, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3327-3327
Open Access | Times Cited: 15
Human tumor-associated macrophages and neutrophils regulate anti-tumor antibody efficacy through lethal and sublethal trogocytosis
Sunil Singhal, Abhishek S. Rao, Jason Stadanlick, et al.
Cancer Research (2024) Vol. 84, Iss. 7, pp. 1029-1047
Open Access | Times Cited: 6
Platelet FcRγ inhibits tumor metastasis by preventing the colonization of circulating tumor cells
Y. Wang, Wei Tian, Rui Li, et al.
European Journal of Pharmacology (2025), pp. 177286-177286
Closed Access
Engineering of anti-cancer human IgA equipped with albumin for enhanced plasma half-life
Simone Mester, Chilam Chan, Marta Lustig, et al.
PNAS Nexus (2025)
Open Access
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy
Fatemeh Sadat Toghraie, Maryam Bayat, Mahsa Sadat Hosseini, et al.
Cellular Oncology (2025)
Open Access
When Therapeutic IgA Antibodies Might Come of Age
Delphine Sterlin, Guy Gorochov
Pharmacology (2020) Vol. 106, Iss. 1-2, pp. 9-19
Open Access | Times Cited: 41
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e003000-e003000
Open Access | Times Cited: 37
Nanotechnology reinforced neutrophil-based therapeutic strategies for inflammatory diseases therapy
Jiahe Wu, Teng Ma, Manning Zhu, et al.
Nano Today (2022) Vol. 46, pp. 101577-101577
Closed Access | Times Cited: 25
Neutrophils: Musketeers against immunotherapy
Kashif Rafiq Zahid, Umar Raza, Soumya Tumbath, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Integrins in Health and Disease—Suitable Targets for Treatment?
Tanja Klaus, Christoph Hieber, Matthias Bros, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 212-212
Open Access | Times Cited: 4
The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer
Natasha Ustyanovska Avtenyuk, Nienke Visser, Edwin Bremer, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7820-7820
Open Access | Times Cited: 35
IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients
Léonie A. N. Staats, Hella Pfeiffer, Jasmin Knopf, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2676-2676
Open Access | Times Cited: 33
Therapeutic exploitation of neutrophils to fight cancer
Mandy Gruijs, Celine Angeli Natascha Sewnath, Marjolein van Egmond
Seminars in Immunology (2021) Vol. 57, pp. 101581-101581
Open Access | Times Cited: 27
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
Leonie M. Behrens, Timo K. van den Berg, Marjolein van Egmond
Cancers (2022) Vol. 14, Iss. 14, pp. 3366-3366
Open Access | Times Cited: 21
Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade
Chilam Chan, Marjolein C. Stip, Maaike Nederend, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008478-e008478
Open Access | Times Cited: 3
The effect of radiation treatment of solid tumors on neutrophil infiltration and function: a systematic review
L. RAYMAKERS, Thijs J. Demmers, Gert J. Meijer, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 3, pp. 845-861
Open Access | Times Cited: 3
Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies
Mao Zhang, Haokai Qin, Yingcheng Wu, et al.
Cancer Biology and Medicine (2024), pp. 1-15
Open Access | Times Cited: 3
Distinct Fcα receptor N-glycans modulate the binding affinity to immunoglobulin A (IgA) antibodies
Kathrin Göritzer, Ayşegül Turupcu, Daniel Maresch, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 38, pp. 13995-14008
Open Access | Times Cited: 32
C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions
Rachel V. Jimenez, Valeriya Kuznetsova, Ashley N. Connelly, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 32
Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41
Maxence Duchemin, Daniela Tudor, Andréa Cottignies-Calamarte, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 28
3D Structures of IgA, IgM, and Components
Shunli Pan, Noriyoshi Manabe, Yoshiki Yamaguchi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12776-12776
Open Access | Times Cited: 24
Immunoglobulin A Glycosylation and Its Role in Disease
Alyssa L. Hansen, Colin Reily, Jan Novák, et al.
Experientia supplementum (2021), pp. 433-477
Closed Access | Times Cited: 23
Combination of chemotherapy with low-dose doxorubicin/Lycium barbarum polysaccharide and photothermal therapy with polypyrrole nanoparticles for treating breast cancer
Lina Sun, Baonan Ma, Cuiling Zuo, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104442-104442
Closed Access | Times Cited: 9
Checkpoint-modulating immunotherapies in tumor treatment: Targets, drugs, and mechanisms
Lu Sun, Lixia Chen, Hua Li
International Immunopharmacology (2018) Vol. 67, pp. 160-175
Closed Access | Times Cited: 30

Scroll to top